Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder characterized by the presence of the oncogenic BCR-ABL1 fusion gene derived from the reciprocal translocation of the long arms of chromosome 9 and chromosome 22 [1]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.